Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Loxo Oncology CS (LOXO)

129.51 -3.55 (-2.67%)

04-24 16:00

Open:

133.67

Pre. Close:

133.06

High:

133.67

Low:

128.79

Volume:

202,109

Market Cap:

3890M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

134.048 - 134.791

134.791 - 135.394

Low:

126.519 - 127.559

127.559 - 128.404

Close:

127.982 - 129.523

129.523 - 130.775

Technical analysis  (as of: 2018-04-24 4:26:34 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 161.81     One year: 189.00

Support:

Support1: 120.13    Support2: 108.75

Resistance:

Resistance1: 138.54    Resistance2: 161.81

Pivot:

125.66

Moving Averages:

MA(5): 132.63     MA(20): 122.41

MA(100): 103.81     MA(250): 85.78

MACD:

MACD(12,26): 4.41     Signal(12,26,9): 3.49

%K %D:

%K(14,3): 77.63     %D(3): 80.95

RSI:

RSI(14): 56.46

52-Week:

High: 138.54  Low: 42.11  Change(%): 168.2

Average Vol(K):

3-Month: 39765  10-Days 34536

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LOXO has closed below upper band by 38.1%. Bollinger Bands are 58.2% wider than normal. The large width of the bands suggest high volatility as compared to LOXO's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-04-16T12:05:10-04:00
Biotech Forum: The Week Ahead

2018-04-16T09:07:09-04:00
Loxo up 6% premarket improved outlook for LOXO-292 after Blueprint data on BLU-667

2018-04-16T08:33:59-04:00
Premarket analyst action - healthcare

2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned

2018-04-13T01:03:46-04:00
Institutional Top Ideas Series: DAFNA Capital Management

2018-04-11T08:34:19-04:00
Loxo teams up with Veracyte to advance development of therapies for genetically defined cancers

2018-04-10T08:13:08-04:00
Illumina and Loxo Oncology team up to develop NGS-based pan-cancer companion diagnostic test

2018-04-10T06:45:00-04:00
Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

30.03

Shares Float (M)

29.64

% Held by Insiders

1.30

% Held by Institutions

Shares Short (K)

3662

Shares Short Prior Month (K)

3090

Stock Financials

EPS

-3.910

EPS Est. Current Year

-4.390

EPS Est. Next Year

-4.600

EPS Est. Next Quarter

-1.210

Forward EPS

-3.500

Book Value (p.s.)

10.600

PEG Ratio

Profit Margin

Operating Margin

-715.47

Return on Assets (ttm)

-32.1

Return on Equity (ttm)

-58.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-4.335

Qtrly Earnings Growth

Operating Cash Flow (M)

107.76

Levered Free Cash Flow (M)

-23.19

atoplab.com

Valuation

P/E

-33.12

P/E Growth Ratio

-0.03

P/BV

12.22

P/S

5117348864.00

P/CF

36.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.